EMA offers enhanced support to non-profit drug developers
The European Medicines Agency (EMA) has launched a pilot to support the translation of basic research developments into medicines that could make a difference in patients’ lives in […]
The European Medicines Agency (EMA) has launched a pilot to support the translation of basic research developments into medicines that could make a difference in patients’ lives in […]
The European Medicines Agency has approved new Covid-19 vaccines that protect against the original SARS-CoV-2 virus and omicron variants. These adapted vaccines are the first updated versions of […]
The European Medicines Agency (EMA) has approved 12 new medicines at the September meeting of its key decision-making panel, the Committee on Human Medicinal Products (CHMP). The expert […]
Children with food allergies, along with their parents, often experience heightened anxiety over risks of casual contact with food allergens. They also wonder whether they should avoid social […]
Since 2020, the Covid-19 pandemic has led to a global increase in the number of people wearing masks to limit the spread of illness. Now, new research co-authored […]
One reason that it’s so difficult to deliver large protein drugs orally is that these drugs can’t pass through the mucus barrier that lines the digestive tract. This […]
A new academic study demonstrates for the first time that scheduling medical appointments later in the week increases patient attendance by over 10 per cent. Missed appointments are […]
The same metabolite is linked to cardiovascular and metabolic diseases. A substance produced by gut microorganisms can lead to scarring and blood vessel damage in patients with scleroderma, […]
A new study published today in Arthritis & Rheumatology led by researchers at Baylor College of Medicine reveals that walking for exercise can reduce new frequent knee pain among people […]
Researchers at the Kennedy Institute, University of Oxford, led by Professor Jagdeep Nanchahal have demonstrated the efficacy of the anti-TNF drug adalimumab for patients with early stage Dupuytren’s […]
Recent media releases/statements on new prescription medicines (POMs) issued by the UK Department of Health and Social Care and its executive NHS agencies, risks flouting the strict regulations […]
Treatment with the biologic drug dupilumab brings relief to children younger than 6 years-old who are suffering with moderate-to-severe atopic dermatitis (eczema) The findings were published on Sept. […]
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.